
Please try another search
By Vlad Schepkov Shares of Viking Therapeutics (NASDAQ:VKTX) are trading down over 15% late into Tuesday's session, in a move linked to the disappointing clinical data posted by VKTX's competitor...
By Scott Kanowsky Investing.com -- Shares in Altimmune, Inc. (NASDAQ:ALT) slumped by more than 54% on Tuesday, touching their lowest level since June, as concerns grew over the safety of its obesity...
Altimmune, Inc. (Nasdaq: NASDAQ:ALT), a clinical-stage biopharmaceutical company (the “Company”), today announced topline results from a Week 24 interim analysis of 160 subjects in its 48-week...
Investing.com - Altimmune (NASDAQ: ALT) reported fourth quarter EPS of $-0.43, $0.07 better than the analyst estimate of $-0.50. Revenue for the quarter came in at $-110K versus the consensus estimate...
Altimmune (NASDAQ:ALT) has filed mixed shelf of: Common Stock Preferred Stock Debt Securities Warrants Units
Altimmune, Inc. (NASDAQ:ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review